Advances in the Treatment of ALL
PROGRAM DESCRIPTION This webcast is intended to improve care of patients with acute lymphoblastic leukemia (ALL) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel ...
PROGRAM DESCRIPTION
This webcast is intended to improve care of patients with acute lymphoblastic leukemia (ALL) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
EDUCATIONAL OBJECTIVES
As a result of participating in the activity, learners should be better able to: Describe the alterations in cytogenetic and molecular alterations in the diagnosis and treatment of patients with ALLEvaluate the CD22 and CD19 monoclonal antibody-based therapies for relapsed/refractory ALL
Read more about this
Write the first review
Join now
to leave a review or read peer reviews!
Resource tags
Show all tags